Utility of pre-procurement bedside liver biopsy in the deceased extended-criteria liver donor

Richard Mangus, Tim C. Borup, Sam Popa, Romil Saxena, Oscar Cummings, A. Joseph Tector

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Introduction: The Indiana Organ Procurement Organization (IOPO) utilizes preoperative bedside liver biopsies in certain extended-criteria donors (ECDs), obtained by the on-site coordinator, to determine the utility of pursuing donation. This study reports the clinical and financial outcomes for this management strategy. Methods: All bedside liver biopsies obtained in ECDs over a five-yr period were reviewed. Study variables included the following: indication for biopsy, biopsy results, taking the case to the operating room, transplantation of the donor liver, and graft survival. All biopsies were processed at a single university center. Results: There were 110 donors biopsied. Primary indications included the following: old age (29%), extensive/current alcohol abuse (26%), hepatitis C-positive serology (21%), obesity (25%), and severely elevated liver function enzymes (18%). Biopsy results demonstrated a potentially transplantable liver in 73 cases (66%), all of whom were taken to the OR (while 37 ruled out for donation based upon liver biopsy [34%]). Of all biopsied livers, 49 ultimately were transplanted (45%). Intra-operative decisions included the following: transplant 51/73 (70%), surgeon decision to exclude 20/73 (27%), nonuse due to finding of malignancy two (3%). Conclusions: Bedside liver biopsy may be a valuable tool to determine the utility in pursuing donation in ECDs, particularly with liver-only donors.

Original languageEnglish
Pages (from-to)1358-1364
Number of pages7
JournalClinical Transplantation
Volume28
Issue number12
DOIs
StatePublished - Dec 1 2014

Fingerprint

Tissue Donors
Biopsy
Liver
Tissue and Organ Procurement
Graft Survival
Financial Management
Serology
Operating Rooms
Hepatitis C
Liver Transplantation
Alcoholism
Obesity
Organizations
Transplants
Enzymes
Neoplasms

Keywords

  • Extended-criteria donor
  • Liver biopsy
  • Liver transplantation
  • Organ procurement

ASJC Scopus subject areas

  • Transplantation
  • Medicine(all)

Cite this

Utility of pre-procurement bedside liver biopsy in the deceased extended-criteria liver donor. / Mangus, Richard; Borup, Tim C.; Popa, Sam; Saxena, Romil; Cummings, Oscar; Tector, A. Joseph.

In: Clinical Transplantation, Vol. 28, No. 12, 01.12.2014, p. 1358-1364.

Research output: Contribution to journalArticle

@article{da54b4737bfb4d63bd44f6b8bb8ee457,
title = "Utility of pre-procurement bedside liver biopsy in the deceased extended-criteria liver donor",
abstract = "Introduction: The Indiana Organ Procurement Organization (IOPO) utilizes preoperative bedside liver biopsies in certain extended-criteria donors (ECDs), obtained by the on-site coordinator, to determine the utility of pursuing donation. This study reports the clinical and financial outcomes for this management strategy. Methods: All bedside liver biopsies obtained in ECDs over a five-yr period were reviewed. Study variables included the following: indication for biopsy, biopsy results, taking the case to the operating room, transplantation of the donor liver, and graft survival. All biopsies were processed at a single university center. Results: There were 110 donors biopsied. Primary indications included the following: old age (29{\%}), extensive/current alcohol abuse (26{\%}), hepatitis C-positive serology (21{\%}), obesity (25{\%}), and severely elevated liver function enzymes (18{\%}). Biopsy results demonstrated a potentially transplantable liver in 73 cases (66{\%}), all of whom were taken to the OR (while 37 ruled out for donation based upon liver biopsy [34{\%}]). Of all biopsied livers, 49 ultimately were transplanted (45{\%}). Intra-operative decisions included the following: transplant 51/73 (70{\%}), surgeon decision to exclude 20/73 (27{\%}), nonuse due to finding of malignancy two (3{\%}). Conclusions: Bedside liver biopsy may be a valuable tool to determine the utility in pursuing donation in ECDs, particularly with liver-only donors.",
keywords = "Extended-criteria donor, Liver biopsy, Liver transplantation, Organ procurement",
author = "Richard Mangus and Borup, {Tim C.} and Sam Popa and Romil Saxena and Oscar Cummings and Tector, {A. Joseph}",
year = "2014",
month = "12",
day = "1",
doi = "10.1111/ctr.12461",
language = "English",
volume = "28",
pages = "1358--1364",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Utility of pre-procurement bedside liver biopsy in the deceased extended-criteria liver donor

AU - Mangus, Richard

AU - Borup, Tim C.

AU - Popa, Sam

AU - Saxena, Romil

AU - Cummings, Oscar

AU - Tector, A. Joseph

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Introduction: The Indiana Organ Procurement Organization (IOPO) utilizes preoperative bedside liver biopsies in certain extended-criteria donors (ECDs), obtained by the on-site coordinator, to determine the utility of pursuing donation. This study reports the clinical and financial outcomes for this management strategy. Methods: All bedside liver biopsies obtained in ECDs over a five-yr period were reviewed. Study variables included the following: indication for biopsy, biopsy results, taking the case to the operating room, transplantation of the donor liver, and graft survival. All biopsies were processed at a single university center. Results: There were 110 donors biopsied. Primary indications included the following: old age (29%), extensive/current alcohol abuse (26%), hepatitis C-positive serology (21%), obesity (25%), and severely elevated liver function enzymes (18%). Biopsy results demonstrated a potentially transplantable liver in 73 cases (66%), all of whom were taken to the OR (while 37 ruled out for donation based upon liver biopsy [34%]). Of all biopsied livers, 49 ultimately were transplanted (45%). Intra-operative decisions included the following: transplant 51/73 (70%), surgeon decision to exclude 20/73 (27%), nonuse due to finding of malignancy two (3%). Conclusions: Bedside liver biopsy may be a valuable tool to determine the utility in pursuing donation in ECDs, particularly with liver-only donors.

AB - Introduction: The Indiana Organ Procurement Organization (IOPO) utilizes preoperative bedside liver biopsies in certain extended-criteria donors (ECDs), obtained by the on-site coordinator, to determine the utility of pursuing donation. This study reports the clinical and financial outcomes for this management strategy. Methods: All bedside liver biopsies obtained in ECDs over a five-yr period were reviewed. Study variables included the following: indication for biopsy, biopsy results, taking the case to the operating room, transplantation of the donor liver, and graft survival. All biopsies were processed at a single university center. Results: There were 110 donors biopsied. Primary indications included the following: old age (29%), extensive/current alcohol abuse (26%), hepatitis C-positive serology (21%), obesity (25%), and severely elevated liver function enzymes (18%). Biopsy results demonstrated a potentially transplantable liver in 73 cases (66%), all of whom were taken to the OR (while 37 ruled out for donation based upon liver biopsy [34%]). Of all biopsied livers, 49 ultimately were transplanted (45%). Intra-operative decisions included the following: transplant 51/73 (70%), surgeon decision to exclude 20/73 (27%), nonuse due to finding of malignancy two (3%). Conclusions: Bedside liver biopsy may be a valuable tool to determine the utility in pursuing donation in ECDs, particularly with liver-only donors.

KW - Extended-criteria donor

KW - Liver biopsy

KW - Liver transplantation

KW - Organ procurement

UR - http://www.scopus.com/inward/record.url?scp=84918781716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918781716&partnerID=8YFLogxK

U2 - 10.1111/ctr.12461

DO - 10.1111/ctr.12461

M3 - Article

C2 - 25203789

AN - SCOPUS:84918781716

VL - 28

SP - 1358

EP - 1364

JO - Clinical Transplantation

JF - Clinical Transplantation

SN - 0902-0063

IS - 12

ER -